Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 406-424
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Sub-Stage | B1 | B2 | B3 | B4 |
Child-Pugh score | 5-6-7 | 5-6 | 7 | 8-9 (with severe/refractory ascites and/or jaundice) |
Beyond Milan and within Ut-7 | In | Out | Out | Any |
ECOG (tumor related) PS | 0 | 0 | 0 | 0-1 |
Portal vein thrombosis | - | - | - | - |
1st option Alternative | TACE Liver transplantaion TACE + ablation | TACE or TARE sorafenib | Research trials TACE sorafenib | BSC Liver transplantaion (only if Up-to-7 IN and PS0) |
- Citation: Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol 2015; 7(3): 406-424
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/406.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.406